A healthcare product is a safe and clinically effective product. Traceability, patient safety and transparency are important commitments for ensuring the sustainability of our field.
In this context, CDMO experts Laboratoires Chemineau have participated for the past two years in a very ambitious clinical study program in partnership with Inserm and the hospital sector on work related to Covid-19 and other respiratory infections.
This goal of this clinical investigation program is to generate clinical evidence in response to its customers’ search for innovative and clinically relevant products.
For more informations, please contact : firstname.lastname@example.org